Edition:
India

People: Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK)

2196.HK on Hong Kong Stock

23.35HKD
8:59am IST
Change (% chg)

HK$-0.05 (-0.21%)
Prev Close
HK$23.40
Open
HK$23.35
Day's High
HK$23.50
Day's Low
HK$23.05
Volume
1,141,530
Avg. Vol
3,114,419
52-wk High
HK$31.50
52-wk Low
HK$19.76

Yin, Hequn 

Mr. Hequn Yin has been serving as Senior Vice President in Shanghai Fosun Pharmaceutical (Group) Co., Ltd. since February 11, 2019. He used to be Vice President-Research & Development in Pfizer Inc. He obtained his Bachelor of Science from Peking University in July 1985, his Master of Science from Shanghai Institute of Organic Chemistry, China Academy of Sciences in June 1988, and his Ph.D. in Pharmacology from University of Rochester, the United States in May 1995.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Qiyu Chen

14,250,400

Fang Yao

9,364,700

Yifang Wu

8,138,200

Xiaohui Guan

3,824,500

Yuqing Chen

3,061,700

Aimin Hui

4,155,800
As Of  31 Dec 2018